RECCHIA, Alessandra
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.639
EU - Europa 4.876
AS - Asia 4.661
SA - Sud America 690
Continente sconosciuto - Info sul continente non disponibili 284
AF - Africa 113
OC - Oceania 58
Totale 23.321
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.266
IT - Italia 1.590
SG - Singapore 1.453
GB - Regno Unito 1.187
CN - Cina 1.168
VN - Vietnam 521
HK - Hong Kong 514
BR - Brasile 510
SE - Svezia 501
DE - Germania 367
BD - Bangladesh 228
FR - Francia 228
RU - Federazione Russa 218
FI - Finlandia 170
UA - Ucraina 169
CA - Canada 165
TR - Turchia 114
KR - Corea 108
IN - India 99
ID - Indonesia 87
NL - Olanda 86
JP - Giappone 71
MX - Messico 64
BG - Bulgaria 60
AR - Argentina 57
BE - Belgio 51
AU - Australia 48
IQ - Iraq 48
ZA - Sudafrica 44
AE - Emirati Arabi Uniti 35
IE - Irlanda 35
LT - Lituania 32
CO - Colombia 30
BZ - Belize 29
PK - Pakistan 28
ES - Italia 27
VE - Venezuela 24
EC - Ecuador 23
MY - Malesia 22
PL - Polonia 21
AT - Austria 19
IR - Iran 19
CH - Svizzera 18
PH - Filippine 18
CR - Costa Rica 17
TT - Trinidad e Tobago 17
CL - Cile 16
CZ - Repubblica Ceca 16
JO - Giordania 16
SA - Arabia Saudita 16
GT - Guatemala 15
MA - Marocco 15
IL - Israele 14
PR - Porto Rico 12
UZ - Uzbekistan 12
NP - Nepal 11
AL - Albania 10
NZ - Nuova Zelanda 10
TH - Thailandia 10
TN - Tunisia 10
CW - ???statistics.table.value.countryCode.CW??? 9
HN - Honduras 9
JM - Giamaica 9
PT - Portogallo 9
SI - Slovenia 9
SV - El Salvador 9
LU - Lussemburgo 8
PE - Perù 8
RO - Romania 8
BO - Bolivia 7
DZ - Algeria 7
EG - Egitto 7
KE - Kenya 7
NI - Nicaragua 7
PY - Paraguay 7
RS - Serbia 7
UY - Uruguay 7
GP - Guadalupe 6
GR - Grecia 6
SC - Seychelles 6
TW - Taiwan 6
AZ - Azerbaigian 5
BY - Bielorussia 5
DO - Repubblica Dominicana 5
PA - Panama 5
PS - Palestinian Territory 5
ET - Etiopia 4
KZ - Kazakistan 4
NG - Nigeria 4
NO - Norvegia 4
OM - Oman 4
QA - Qatar 4
DK - Danimarca 3
EU - Europa 3
GE - Georgia 3
KG - Kirghizistan 3
LB - Libano 3
LK - Sri Lanka 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
Totale 23.018
Salva come PNG Salva come JPEG
Città #
Ashburn 1.364
Fairfield 1.041
Singapore 981
Santa Clara 960
San Jose 795
Southend 746
Chandler 598
Woodbridge 587
Houston 504
Hong Kong 491
Seattle 385
Council Bluffs 384
Cambridge 365
Ann Arbor 336
Wilmington 321
Jacksonville 304
Dearborn 279
Nyköping 274
Hefei 262
Beijing 244
Los Angeles 221
Modena 216
Chicago 189
London 187
New York 165
Ho Chi Minh City 143
Bologna 133
Helsinki 125
Hanoi 120
The Dalles 117
San Diego 106
Seoul 92
Milan 87
Buffalo 77
Princeton 76
Columbus 69
Dallas 66
Moscow 65
Salt Lake City 65
Jakarta 63
Lauterbourg 59
Sofia 59
Bremen 55
Rome 53
Eugene 52
Shanghai 50
Brussels 49
Izmir 49
Phoenix 45
Orem 41
Toronto 41
Boardman 40
Elk Grove Village 40
São Paulo 40
Munich 39
Frankfurt am Main 36
Tampa 34
Tokyo 33
Da Nang 32
Redwood City 32
Des Moines 31
San Francisco 31
Brooklyn 30
Falls Church 30
Belize City 29
Parma 28
Montreal 27
Dublin 26
Atlanta 25
Dong Ket 25
Haiphong 25
Las Vegas 25
Bari 24
Mexico City 24
Paris 24
Boston 23
Naples 22
Rio de Janeiro 21
Boydton 19
Denver 19
Mumbai 19
North Bergen 19
Turin 19
Amsterdam 18
Baghdad 18
Chennai 17
Johannesburg 17
Lancaster 17
Warsaw 17
Sterling 16
Trieste 16
Guangzhou 15
Nuremberg 15
Stockholm 15
Wuhan 15
Biên Hòa 14
Miami 14
Newark 14
Poplar 14
Albuquerque 13
Totale 15.312
Salva come PNG Salva come JPEG
Nome #
Closure of a Large Chronic Wound through Transplantation of Gene-Corrected Epidermal Stem Cells 621
IL-7 and IL-15 instruct the generation of human memory stem T cells from naïve precursors 518
Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells 495
In vivo editing of the human mutant Rhodopsin gene by electroporation of plasmid-based CRISPR/Cas9 in the mouse retina 473
CRISPR/Cas9-Mediated In Situ Correction of LAMB3 Gene in Keratinocytes Derived from a Junctional Epidermolysis Bullosa Patient 469
Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer 450
Inducible Caspase9-mediated suicide gene for MSC-based cancer gene therapy 447
MSC-delivered soluble TRAIl and paclitaxel as novel combinatory treatment for pancreatic adenocarcinoma 442
CRISPR/Cas9-mediated specific knock-down of dominant mutations in Rhodopsin gene 435
Transcription factor binding sites are genetic determinants of retroviral integration in the human genome. 422
CRISPR/Cas9 gene editing in vitro and in retinal cells in vivo 421
Targeted Gene Addition in Human Epithelial Stem Cells by Zinc-finger Nuclease-mediated Homologous Recombination 417
Long-term stability and safety of transgenic cultured epidermal stem cells in gene therapy of junctional epidermolysis bullosa. 403
Correction of recessive dystrophic epidermolysis bullosa by transposon-mediated integration of COL7A1 in transplantable patient-derived primary keratinocytes. 401
Transcriptionally regulated and nontoxic delivery of the hyperactive Sleeping Beauty Transposase 394
Bimodal CD40/Fas-Dependent Crosstalk between iNKT Cells and Tumor-Associated Macrophages Impairs Prostate Cancer Progression 384
Transcriptionally regulated and non-toxic delivery of the hyperactive Sleeping Beauty Transposase 383
Comprehensive genomic access to vector integration in clinical gene therapy 382
Retroviral vector integration deregulates gene expression but has no consequence on the biology and function of transplanted T cells 377
Targeted gene integration in human epidermal stem cells by Zinc-finger nuclease-mediated homologous recombination. 361
Genomic Analysis of Sleeping Beauty Transposon Integration in Human Somatic Cells 360
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 359
Site-specific integration by the adeno-associated virus rep protein 354
A single epidermal stem cell strategy for safe ex vivo gene therapy 354
Nuclear architecture dictates HIV-1 integration site selection 353
Hot spots of retroviral integrations in human CD34+ hematopoietic cells 347
Long-Term Skin Regeneration From a Gene-Targeted Human Epidermal Stem Cell Clone 338
Design of a regulated lentiviral vector for hematopoietic stem cell gene therapy of globoid cell leukodystrophy 338
Development of a Sleeping Beauty transposon-based integration system for gene transfer in human epithelial cells 338
In vitro and in vivo CRISPR/Cas9-mediated genome editing to downregulate dominant mutations in Rhodopsin gene 334
Absence of an intrathecal immune reaction to a helper-dependent adenoviral vector delivered into the cerebrospinal fluid of non-human primates. 334
AAV-CRISPR Persistence in the Eye of the Beholder 330
An efficient in vitro transposition method by a transcriptionally regulated sleeping beauty system packaged into an integration defective lentiviral vector 328
High-definition mapping of retroviral integration sites defines the fate of allogeneic T cells after donor lymphocyte infusion. 327
In vitro and in vivo genome editing of the RHO gene to downregulate dominant mutations 316
Site-specific integration of functional transgenes into the human genome by adeno/AAV hybrid vectors 315
Site-specific integration into the human genome: Ready for clinical application? 312
Tracking gene-modified T cells in vivo. 308
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 306
Collagen VII gene delivery via Sleeping Beauty transposon in COL7A1-deficient keratinocytes from epidermolysis bullosa patients 299
Non viral gene transfer via Sleeping beauty transposon for Collagen VII delivery in human primary keratinocytes. 293
Transcriptional enhancers induce insertional gene deregulation independently from the vector type and design 293
Genotoxic signature in cord blood cells of newborns exposed in utero to a zidovudine-based antiretroviral combination 291
Defining the lentiviral integrome in human hematopoietic cells 287
Site-specific integration in mammalian cells mediated by a new hybrid baculovirus-adeno-associated virus vector 286
Site-specific integration mediated by a hybrid adenovirus/adeno-associated virus vector 280
Gene editing prospects for treating inherited retinal diseases 279
CRISPR-mediated T cell engineering against Non-Small Cell Lung Cancer 276
Allele-specific editing ameliorates dominant retinitis pigmentosa in a transgenic mouse model 275
Immunotherapy: ANTI-GD2 CAR T CELLS AGAINST SMALL CELL LUNG CANCER 268
Differential integrity of TALE nuclease genes following adenoviral and lentiviral vector gene transfer into human cells 263
CRISPR/Cas9 Allele-Specific Design To Inactivate A Dominant-Negative Mutation In COL6A1 Causing Ullrich Muscular Dystrophy 263
Beta1 integrin activates Rac1 in Schwann cells to generate radial lamellae during axonal sorting and myelination 260
Targeted integration of a large transgene cassette by TALEN and ZFN-mediated homologous recombination. 257
Engineered Sleeping Beauty Transposon as Efficient System to Optimize Chimp Adenoviral Production 256
Relative influence of the adeno-associated virus (AAV) type 2 p5 element for recombinant AAV vector site-specific integration 253
Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy 240
IL4 gene delivery to the CNS recruits regulatory T cells and induces clinical recovery in mouse models of multiple sclerosis 231
Transcriptional and epigenetic analyses of the DMD locus reveal novel cisâ acting DNA elements that govern muscle dystrophin expression 217
Erratum: Genomic analysis of sleeping beauty transposon integration in human somatic cells (PLoS ONE (2014) 9:11 (e112712) DOI: 10.1371/journal.pone.0112712) 204
CRISPR-Mediated Genome Editing to Redirect T Cells against Non-Small Cell Lung Cancer 198
Efficient CRISPR/Cas9-Mediated iIn Situ Correction of LAMB3 Gene in Keratinocytes Derived from Junctional Epidermolysis Bullosa Patient 198
CRISPR/Cas9 allele-specifc design to inactivate a dominant-negative mutation in COL6A1 causing Ullrich muscular dystrophy. 195
CRISPR-mediated genome editing to redirect T cells against Non-Small Cell Lung Cancer 194
Corrigendum to: “Transcriptional and epigenetic analyses of the DMD locus reveal novel cis-acting DNA elements that govern muscle dystrophin expression”. [Biochim. Biophys. Acta Gene Regul. Mech. 2017 Nov;1860(11):1138–1147.] (Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms (2017) 1860(11) (1138–1147), (S1874939917301359), (10.1016/j.bbagrm.2017.08.010)) 180
In vitro and in vivo genome editing of the RHO gene to downregulate dominant mutations 177
Induced Pluripotent Stem Cells and Genome-Editing Tools in Determining Gene Function and Therapy for Inherited Retinal Disorders 174
CRISPR-mediated genome editing to redirect T cells against Non-Small Cell Lung Cancer 173
Collagen VII gene delivery via an Adeno-Sleeping Beauty transposon in COL7A1-deficient keratinocytes from epidermolysis bullosa patients 173
Specific Knock-down of P347S Dominant Mutation in Rhodopsin Gene by CRISPR/Cas9 System 169
Restored Collagen VI Microfilaments Network in the Extracellular Matrix of CRISPR-Edited Ullrich Congenital Muscular Dystrophy Fibroblasts 166
Specific knock-down of C-terminal dominant mutation in Rhodopsin gene by CRISPR/Cas9 system 156
The Journal of Gene Medicine European Society of Gene Therapy Young Investigator Award 2004 155
TALEN-mediated in situ correction of a genetic defect by homologous recombination into the native locus 151
Engineered nucleases-mediated in situ correction of a genetic defect by homologous recombination into the native locus 149
Profibrotic Molecules Are Reduced in CRISPR-Edited Emery–Dreifuss Muscular Dystrophy Fibroblasts 96
Totale 23.321
Salva come PNG Salva come JPEG
Categoria #
all - tutte 88.998
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.998
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.196 0 0 0 0 113 101 132 123 145 112 279 191
2022/20231.921 211 207 165 218 243 257 50 160 207 25 96 82
2023/20241.186 53 72 93 99 217 70 113 147 28 84 83 127
2024/20253.502 105 46 131 229 664 517 274 251 355 184 341 405
2025/20266.637 419 221 428 737 1.242 425 755 258 674 641 473 364
2026/20272.107 221 444 534 762 146 0 0 0 0 0 0 0
Totale 23.321